Results guide your provider's dose optimization and medication choice, increasing your odds of meaningful weight loss and treatment satisfaction
Pausing to adjust the thermostat as he came in, he fell, knocking over a lamp
Common adverse effects of GLP-1 receptor agonists include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation) Injection site reactions Headache Fatigue Dizziness Important safety considerations include: Risk of hypoglycaemia when used with insulin or sulfonylureas (dose reduction of these agents may be needed) Potential worsening of diabetic retinopathy with semaglutide in patients with pre-existing retinopathy Risk of dehydration and acute kidney injury from persistent vomiting or diarrhoea Pancreatitis, gallbladder disease, and potential thyroid C-cell tumours (observed in rodent studies, though human relevance remains uncertain) Patients should be counselled about persistent severe abdominal pain as a potential warning sign of pancreatitis requiring immediate medical attention
I look forward to see our country and those in their 'Golden Years' receive the best that America has to offer next year and beyond
If you keep feeling sick, talk with your doctor
Results showed GLP-1 use gradually rising among patients with MASH and compensated cirrhosis since 2018, with a sharp increase from 2022 (11.2%) to 2024 (18.3%)
